Intragastric Balloon with Novel Inflate/Deflate Mechanism and Reduced Risk in Patients
CARAMELTECH, Mexico City, Mexico
A novel intragastric balloon was developed providing many advantages compared to other obesity treatment alternatives such as: lower cost, stomach device fixation, no mortality, low morbility rate, only requires an ambulatory procedure, and innovative addition of a subcutaneous valve which allows anytime inflate/deflate by physician.
Primary Application Area: Medical Devices
Technology Development Status: Ready to Market
Technology Readiness Level: TRL 5
FIGURES OF MERIT
Value Proposition: The technology provides several highlights compared to other obesity surgical treatments: lower cost, stomach device fixation, no mortality rate, less morbility rate, only requires an ambulatory procedure, and innovative addition of a subcutaneous valve which allows anytime inflate/deflate by physician.
Organization Type: Mid-stage Startup (A or B)
Showcase Booth #: 755
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date: CONACyT (National Council on Science and Technology) and Mexico'S Economy Ministry contributed with approximately US$130,000 which was applied for: payment of necessary instrumental, importation expenses, devices’ sterilization, manufacturing of 40 devices, international patents management, device application for 25 patients, medical expenses, civil responsibility insurance, patient validation, sanitary regulation, diffusion travel and per diem for commercialization, package design, administration financial requirements, and marketing expenses.
Primary Sources of Funding: Angel, Friends, Family, Corporate Partner, Federal Grant
Looking for: Both Funding and Development Partners